Firstpoint Biotech

FirstPoint Biotech is a global portfolio organization adopting a ‘buy and build’ strategy, providing shared management and infrastructure, a unified brand and financial operations and shared development resources such as clinical research to support the development of drugs and devices by its portfolio companies. The FirstPoint brand will include healthcare products addressing high value unmet clinical needs, and healthcare-related services. The first acquisition targets have been identified, have undergone rigorous due diligence, and favourable financial terms have been agreed. A world-class core management team and scientific advisory board have been assembled. Funding for this new venture is under active negotiation.